Fabrication, in vitro and in vivo studies of bilayer composite membrane for periodontal guided tissue regeneration.
Saba ZahidAbdul Samad KhanAqif Anwar ChaudhrySarah GhafoorQurat Ul AinAhtasham RazaMuhammad Imran RahimOliver GoerkeIhtesham Ur RehmanAsma Tufail ShahPublished in: Journal of biomaterials applications (2018)
Development of a guided occlusive biodegradable membrane with controlled morphology in order to restrict the ingrowth of epithelial cells is still a challenge in dental tissue engineering. A bilayer membrane with a non-porous upper layer (polyurethane) and porous lower layer (polycaprolactone and bioactive glass composite) with thermoelastic properties to sustain surgery treatment was developed by lyophilization. Morphology, porosity, and layers attachment were controlled by using the multi-solvent system. In vitro and in vivo biocompatibility, cell attachment, and cell proliferation were analyzed by immunohistochemistry and histology. The cell proliferation rate and cell attachment results showed good biocompatibility of both surfaces, though cell metabolic activity was better on the polycaprolactone-bioactive glass surface. Furthermore, the cells were viable, adhered, and proliferated well on the lower porous bioactive surface, while non-porous polyurethane surface demonstrated low cell attachment, which was deliberately designed and a pre-requisite for guided tissue regeneration/guided bone regeneration membranes. In addition, in vivo studies performed in a rat model for six weeks revealed good compatibility of membranes. Histological analysis (staining with hematoxylin and eosin) indicated no signs of inflammation or accumulation of host immune cells. These results suggested that the fabricated biocompatible bilayer membrane has the potential for use in periodontal tissue regeneration.
Keyphrases
- tissue engineering
- single cell
- cell proliferation
- stem cells
- cell therapy
- oxidative stress
- bone regeneration
- escherichia coli
- minimally invasive
- induced apoptosis
- highly efficient
- risk assessment
- drug delivery
- cell cycle
- bone marrow
- pseudomonas aeruginosa
- staphylococcus aureus
- endoplasmic reticulum stress
- mesenchymal stem cells
- cystic fibrosis
- combination therapy
- human health
- replacement therapy
- preterm birth